Do you know TAFRO?
- PMID: 30442745
- DOI: 10.1182/blood-2018-09-875112
Do you know TAFRO?
Conflict of interest statement
Conflict-of-interest disclosure: M.A.L. reports research grants from Celgene, Curis, Janssen Scientific Affairs, LLC, Juno Therapeutics, Pharmacyclics, and TG Therapeutics and consulting relationships with AbbVie, ADC Therapeutics, Astra-Zeneca/Acerta, Bayer, Celgene, Genentech, Gilead Sciences, Inc, Janssen/Pharmacyclics, Juno Therapeutics, Kite, Portola, Sanofi-Genzyme, Seattle Genetics, Spectrum, TG Therapeutics, Verastem. J.O.A. reports consulting relationships with Conatus IDMC, Samus Therapeutics, Oncology Analytics, and Ascentage; he is a member of the Board of Directors for Tesaro Bio, Inc.
Comment on
-
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Blood. 2018. PMID: 30181172 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources